| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Financial Officer
2 companies
Burke William P. Mr. is an EVP, Chief Financial Officer at HAEMONETICS CORP with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 16 sells.
Estimated insider holdings value: $1.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 11, 2025 | AXGN Axogen, Inc. | Director | Sale+OE | 22,818 | $24.01 | $547,888.91 | -99.1% | +38.7% | - | |
| Nov 6, 2025 | AXGN Axogen, Inc. | Director | Sale+OE | 16,778 | $24.04 | $403,263.46 | -98.8% | +42.6% | - | |
| Oct 30, 2025 | AXGN Axogen, Inc. | Director | Sale+OE | 58,483 | $21.32 | $1,246,717.23 | -99.5% | +50.4% | - | |
| Oct 22, 2025 | AXGN Axogen, Inc. | Director | Sell | 1,457 | $18.02 | $26,252.23 | -93.6% | +76.6% | - | |
| Oct 6, 2025 | AXGN Axogen, Inc. | Director | Sell | 736 | $18.00 | $13,248.74 | -32.1% | +85.1% | - | |
| Oct 3, 2025 | AXGN Axogen, Inc. | Director | Sell | 32,191 | $18.14 | $584,074.05 | -54.6% | +73.4% | - | |
| Jun 9, 2025 | AXGN Axogen, Inc. | Director | Sell | 4,073 | $10.61 | $43,214.53 | -14.3% | +54.1% | - | |
| Aug 23, 2023 | AXGN Axogen, Inc. | Director | Buy | 10,000 | $6.56 | $65,600.00 | New | -8.6% | +89.4% | |
| Aug 23, 2021 | HAE Haemonetics Corp | EVP, Chief Financial Officer | Sale+OE | 22,667 | $60.51 | $1,371,580.17 | -42.8% | -9.5% | +24.0% | |
| Jul 1, 2021 | HAE Haemonetics Corp | EVP, Chief Financial Officer | Sell | 4,293 | $66.60 | $285,913.80 | -12.4% | +4.0% | -0.6% |